Undeniable Reasons to Take Social Security at 70 Now
As retirement costs rise and markets stay volatile, delaying Social Security to age 70 can deliver a bigger, guarante...
Ways To Adjust Your Budget For New Costs
New costs require quick yet thoughtful budget tweaks. This section highlights practical adjustments to preserve balance and grow savings.
27,302 articles
How a Fake Apple Pop-Up Led to a $20,000 Cash Send
A pop-up that looked like Apple Support pulled a woman into withdrawing thousands and shipping cash by Uber. This cau...
Wall Street Sees Upside in This Overlooked Tech Stock
Analysts tout gains for an overlooked tech name, but the upside may be clouded by rising costs, competition, and macr...
Housing Market Stuck: Opendoor Buying Fastest Since 2022
The housing market may feel stuck, with fewer bidding wars and rising delistings, but Opendoor is breaking through th...
Warren Buffett Explained Netflix's AI Edge Won't Last
Buffett’s moat mindset helps explain Netflix's AI edge. This article breaks down why the advantage may be temporary a...
Rocket Stock Gained 118%: Is It Time to Buy in 2025?
Rocket Lab’s stock jumped about 118% in the last year, but a big move doesn’t always mean a lasting uptrend. This art...
Billionaire Investor Jeremy Grantham: Bitcoin Isn’t Useless After All
Critics like the billionaire investor jeremy grantham call Bitcoin a mere speculative asset. This article argues why ...
Lynx Investment Advisory Million Stake in Akre Focus ETF
Lynx Investment Advisory recently disclosed a meaningful stake in the Akre Focus ETF, signaling confidence in a quali...
AT&T: Should Investors Into the Turnaround Strategy
AT&T has been through a long turnaround, shedding assets and tightening the balance sheet. This article weighs the ca...
Spacex Date: What Investors Need Before the SPCX IPO
SpaceX is eyeing a historic IPO. This guide explains the spacex date: what investors should watch, how pricing could ...
Warsh Signals Hidden Tools Fight Inflation, Investors React
Federal Reserve Chair Kevin Warsh is signaling a second inflation-fighting tool beyond traditional rate changes. Inve...
Iovance Biotherapeutics: High-Risk Cancer Stock Potential
A bold, high‑risk biotech bet can pay off with patience and discipline. This article breaks down iovance biotherapeut...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status